MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Female Health Co Company Profile (NASDAQ:FHCO)

Consensus Ratings for Female Health Co (NASDAQ:FHCO) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Female Health Co (NASDAQ:FHCO)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings History for Female Health Co (NASDAQ:FHCO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
4/28/2016        
2/2/2016Q1$0.05$6.66 million$8.23 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q315$0.06$7.28 million$7.81 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q215$0.07$0.06$9.48 million$11.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2015Q115$0.07$0.03$9.91 million$6.66 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/2/2014Q314$0.02($0.02)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q214$0.05$0.04$7.28 million$7.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014$0.02$0.01ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2014Q114$0.05$0.05$9.91 million$6.69 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/3/2013Q4$0.14$0.23$9.90 million$4.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q2 2013$0.12$7.80 million$9.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2013Q1 2013$0.12$8.60 million$9.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Female Health Co (NASDAQ:FHCO)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Female Health Co (NASDAQ:FHCO)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
3/25/2014quarterly$0.073.84%4/28/20144/30/20145/7/2014Tweet This Announcement  Share This Announcement on StockTwits
3/24/2014quarterly$0.074/30/20144/7/2014Tweet This Announcement  Share This Announcement on StockTwits
12/16/2013quarterly$0.073.56%1/27/20141/29/20142/5/2014Tweet This Announcement  Share This Announcement on StockTwits
10/4/2013quarterly$0.072.87%10/28/201310/30/201311/6/2013Tweet This Announcement  Share This Announcement on StockTwits
7/16/2013quarterly$0.072.99%7/29/20137/31/20138/7/2013Tweet This Announcement  Share This Announcement on StockTwits
3/27/2013quarterly$0.073.87%4/29/20135/1/20135/8/2013Tweet This Announcement  Share This Announcement on StockTwits
1/3/2013quarterly$0.063.25%1/28/20131/30/20132/6/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Female Health Co (NASDAQ:FHCO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/10/2016Andrew S Love JrDirectorBuy15,000$1.36$20,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2016Andrew S Love JrDirectorBuy1,210$1.40$1,694.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2016Michele GrecoCFOBuy4,000$1.28$5,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2016O B ParrishCEOBuy10,000$1.29$12,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2016William R Gargiulo JrDirectorBuy500$1.26$630.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016David R BethuneDirectorBuy100$1.26$126.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2015O B ParrishCEOBuy10,000$1.48$14,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2015Andrew S. Love, Jr.DirectorBuy25,000$1.47$36,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2015Karen Louise KingCEOBuy1,000$3.86$3,860.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014O B ParrishDirectorBuy5,000$4.05$20,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/6/2014Donna FelchDirectorBuy2,500$3.90$9,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014Karen Louise KingCEOBuy2,000$3.94$7,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014Stephen M DearholtDirectorSell203,936$6.05$1,233,812.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014William R Gargiulo JrDirectorBuy1,000$6.81$6,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014O B ParrishDirectorBuy5,000$6.74$33,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/20/2013Stephen M DearholtDirectorBuy2,000$8.27$16,540.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2013David R BethuneDirectorBuy4,000$8.07$32,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/8/2013Michele GrecoCFOBuy1,000$7.01$7,010.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2012Stephen M DearholtDirectorSell25,000$7.02$175,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/9/2012Michael PopeVPSell17,056$5.90$100,630.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2012Richard E WenningerDirectorSell3,260$6.00$19,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Female Health Co (NASDAQ:FHCO)
DateHeadline
06/14/16 08:49 AMDirector of Female Healthny (NASDAQ:FHCO), Love Andrew S Jr, buys 15,000 shares worth $20,400
06/03/16 10:36 AMFEMALE HEALTH CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
06/03/16 10:35 AMThe Female Health Company to Present at LD Micro Invitational Investor Conference on Tuesday, June 7, 2016 - [at noodls] - CHICAGO, June 03, 2016 (GLOBE NEWSWIRE) -- The Female Health Company (FHC) (NASDAQ:FHCO), manufacturer of the world's leading female condom, the FC2, today announced that it will be presenting at the LD ...
05/26/16 05:37 PMBrazilian Ministry of Health to Distribute 100,000 FC2s from The Female Health Company at the 2016 Summer Olympics in Rio de Janeiro - [at noodls] - CHICAGO, May 26, 2016 (GLOBE NEWSWIRE) -- The Female Health Company (NASDAQ:FHCO) (FHC) today announced that the Ministry of Health in Brazil will distribute 100,000 of FHC's FC2 Female Condoms to the ...
04/07/16 08:44 AMThe Female Health Company to host conference call on April 13 to discuss Aspen Park merger -
04/06/16 07:57 PMBenzinga's M&A Chatter for Wednesday April 6, 2016 - The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday April 6, 2016: The Female Health Company Enters Merger Agreement with Aspen Park Pharmaceuticals The Deal:The Female Health Company (NASDAQ: FHCO) announced Wednesday, that it has entered into a merger agreement with privately held Aspen Park Pharmaceuticals, Inc. Aspen Park is focused on the development and commercialization of oncology and men's and women's health therapeutics and consumer health products. The merger is expected to close in Q3 of 2016. Female Health Company closed at $1.41 on Wednesday, down 18%. Shire Says Still Confident in Baxalta Transaction Despite Treasury Headwinds The Company Comments:Shire plc (NASDAQ: SHPG) acknowledged on Wednesday, the US Treasury notice of April 4, 2016, and anticipates the Baxalta (NYSE: Full story available on Benzinga.com
04/06/16 09:26 AMBRIEF-Female health co says proposed merger approved by both boards - * The Female Health Company enters into transformational merger agreement with Aspen Park Pharmaceuticals
02/18/16 07:30 AMThe Female Health Company Featured in Documentary Television Series "Big Questions" - [GlobeNewswire] - CHICAGO, Feb. 18, 2016-- The Female Health Company today announced that it will be featured in an upcoming episode of "Big Questions," an Emmy ® Award winning documentary television series that ...
02/12/16 04:10 PMFEMALE HEALTH CO Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits -
02/03/16 12:28 PMLosses extended over recession concerns - The Female Health Co. (Nasdaq: FHCO) reported higher first quarter earnings and revenue. On the downside Waddell & Reed Financial (NYSE: WDR) disappointed with lower fourth quarter earnings and revenue. Carbylan Therapeutics (Nasdaq: CBYL) reported ...
02/03/16 12:28 PMFemale Health Co. Ready To Make An Acquisition? - FHCO has a virtual monopoly on the female condom market, and is signaling towards an ... as most of their product is sold to organizations such as the United Nations and World Health Organization and their affiliates, while a portion of sales direct ...
02/02/16 07:32 AM8:32 am Female Health reports Q1 EPS of $0.05 vs $0.03 year ago; revs 24% to $8.23 mln with Unit sales +27% to 15.4 mln (no estimates) -
02/02/16 07:30 AMThe Female Health Company Reports Fiscal 2016 First Quarter Operating Results - [GlobeNewswire] - Unit sales increased 27% to 15.4 million from 12.2 million in the prior-year period. Net revenues increased 24% to $8.2 million from $6.7 million in the prior-year period. Gross profit up 41% to $5.4 million ...
02/02/16 06:07 AMQ1 2016 Female Health Co Earnings Release - Time Not Supplied -
01/26/16 07:59 AMThe Female Health Company to Report First Quarter Operating Results on Tuesday, February 2, 2016 - [at noodls] - , (GLOBE NEWSWIRE) -- The (NASDAQ:FHCO) today announced that it will host an investor conference call to discuss its operating results for the first quarter of FY2016 on at (ET). The Company expects to ...
01/23/16 11:21 AMThe Female Health Company (FHCO) - 4-Jan-16 FEMALE HEALTH CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive 2-Dec-15 FEMALE HEALTH CO Files SEC form 10-K, Annual Report 1-Dec-15 FEMALE HEALTH CO Files SEC form 8-K, Results of Operations ...
01/04/16 03:24 PMFEMALE HEALTH CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive -
01/04/16 07:48 AMThe Female Health Company Announces $10 Million Credit Facility With BMO Harris Bank - [at noodls] - , (GLOBE NEWSWIRE) -- The (NASDAQ:FHCO) today announced a new revolving credit facility with . The new credit line replaces a smaller credit facility with another lender. ... This is an abstract of the ...
12/08/15 12:18 PMFEMALE HEALTH CO Financials -
12/02/15 02:26 PMThe Female Health Co.: Price momentum supported by strong fundamentals -
12/02/15 05:05 AMFEMALE HEALTH CO Files SEC form 10-K, Annual Report -
12/01/15 09:27 AMFEMALE HEALTH CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
12/01/15 07:30 AMThe Female Health Company Reports Fourth Quarter and Fiscal Year 2015 Operating Results - [GlobeNewswire] - 61 Million Units Sold in FY2015. Year– Unit sales up 43% to 61.0 million.– Net revenues up 33% to $32.6 million.– Gross profit up 45% to $19.0 million or 58% of net revenues versus 54% in FY2014.– Operating ...
12/01/15 06:07 AMQ4 2015 Female Health Co Earnings Release - Before Market Open -
11/24/15 03:59 PMThe Female Health Company To Report FY2014 Operating Results on Tuesday, December 2, 2014 - [at noodls] - Investor Conference Call Scheduled for 11:00 a.m. EST CHICAGO, Nov. 24, 2014/PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO), today announced that it will host an investor conference call to ...
11/20/15 07:58 AMThe Female Health Company to Report FY2015 Operating Results on Tuesday, December 1, 2015 - [at noodls] - Investor Conference Call Scheduled for 11:15 a.m. ET CHICAGO, Nov. 20, 2015 (GLOBE NEWSWIRE) -- The Female Health Company (NASDAQ:FHCO), today announced that it will host an investor conference call to ...
About Female Health Co

The Female Health Company is engaged in development, manufacture, and marketing of consumer healthcare products. The Company manufactures, markets and sells FC2 Female Condom (FC2). Its FC2 is primarily used for disease prevention and family planning. The Company's FC2 product facilitates dual protection for women against both unintended pregnancy and sexually transmitted infections (STIs), including human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS). Public health sector is the Company's main market. It offers FC2 in over 140 countries. It also offers male condoms. It offers FC2 from a nitrile polymer formulation. FC2 consists of a soft, loose fitting sheath and two rings: an external ring of rolled nitrile and a loose internal ring made of flexible polyurethane. FC2's soft sheath lines the vagina, preventing skin-to-skin contact during intercourse. Its external ring remains outside the vagina, partially covering the external genitalia.

Industry, Sector and Symbol:
  • Sector: Consumer Goods
  • Industry: Personal Products
  • Sub-Industry: Personal Products
  • Exchange: NASDAQ
  • Symbol: FHCO
  • CUSIP: 31446210
Key Metrics:
  • Previous Close: $1.26
  • 50 Day Moving Average: $1.34
  • 200 Day Moving Average: $1.55
  • P/E Ratio: 12.00
  • P/E Growth: 0.00
  • Market Cap: $38.35M
  • Current Quarter EPS Consensus Estimate: $0.15 EPS
Additional Links:
Female Health Co (NASDAQ:FHCO) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha